You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Per meeting on April 28:
a CTO term of “investigational molecular entity administration” and subclasses “investigational drug administration”, “investigational supplement administration” are created.
a RO relation “has agent” is used to link an investigational molecular entity and its administration process.
New terms added on 6/10/2021.
However, the term "has clinical trial site" is questionable. The intend for creating this term is to capture the countries info in the CT.gov in PubChem RDF. The clinical trial site is broader than the country. We may need to make this relation more specific by changing the label.
Per meeting on April 28:
a CTO term of “investigational molecular entity administration” and subclasses “investigational drug administration”, “investigational supplement administration” are created.
a RO relation “has agent” is used to link an investigational molecular entity and its administration process.
Per meeting on June 3:
Lists of properties need to be added
https://docs.google.com/spreadsheets/d/1zgVAraGxL_KKQkS1MTt2tQoQE9jp_k5GL9385KhXZqE/edit?usp=sharing
The text was updated successfully, but these errors were encountered: